Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz

摘要

Use of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione for the manufacture of a medicine for preventing and treating the progression of hepatic fibrosis and cirrhosis. Optionally, wherein the medicine is formulated as a form selected from the group consisting of a hard capsule, a tablet, a soft capsule, a suspension, a syrup, an injection, and a powder.